Novo Nordisk’s (NYSE:NVO) Ozempic diabetes treatment, marketed as a weight loss treatment under the Wegovy brand name, has become the latest mega-blockbuster drug. Yet, while you may be thinking about ways to capitalize on its popularity and the rise of other glucagon-like peptide-1 (GLP-1) weight loss treatments, you should also consider the stocks to sell
0 Comments
Small-cap stocks attract significant attention from investors due to their more attractive valuations than large-cap peers, presenting opportunities for substantial returns. The previous year was dominated by the “Magnificent Seven,” which drove nearly all the gains in the S&P 500 and Nasdaq indices.  However, this year could mark a turning point for small-cap stocks as
0 Comments
Despite progress, the electric vehicle (EV) industry still relies upon subsidies and tax incentives to increase adoption. These monies counter the high cost of batteries that put EVs above the price of average gasoline-powered cars. Given these economic dependencies, investors might consider evaluating their portfolios for EV stocks to sell, especially those companies most vulnerable
0 Comments
Let me be clear: investing in biotech stocks isn’t for everyone. Investing in smaller biotech companies requires research, patience, and risk tolerance. Investing in A-rated biotech stocks offers high return potential if they make significant advancements in health care. Biotech stocks represent companies that are involved in the research and development of drugs, therapies and
0 Comments
Just like in arguably most sports, balance is everything. The same applies to dividend stocks to buy. Yes, the high-flying growth names tend to attract the most attention. Frankly, there’s nothing wrong with pursuing select names in the space. However, you also want to lean into enterprises that provide passive income. Let’s take a look
0 Comments